Concepts (54)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Patient Selection | 1 | 2025 | 484 | 0.770 |
Why?
|
| Clinical Trials as Topic | 1 | 2025 | 462 | 0.740 |
Why?
|
| Neoplasms | 1 | 2025 | 1376 | 0.440 |
Why?
|
| Bridged Bicyclo Compounds, Heterocyclic | 2 | 2019 | 22 | 0.300 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 2 | 2019 | 47 | 0.290 |
Why?
|
| Sulfonamides | 2 | 2019 | 134 | 0.280 |
Why?
|
| SEER Program | 1 | 2025 | 75 | 0.230 |
Why?
|
| Antigens, CD19 | 1 | 2025 | 25 | 0.230 |
Why?
|
| Mediastinal Neoplasms | 1 | 2025 | 21 | 0.230 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2025 | 67 | 0.220 |
Why?
|
| Graft vs Host Disease | 1 | 2025 | 113 | 0.210 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2025 | 105 | 0.210 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2025 | 93 | 0.200 |
Why?
|
| Oncologists | 1 | 2023 | 18 | 0.200 |
Why?
|
| Hodgkin Disease | 1 | 2023 | 54 | 0.200 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2025 | 184 | 0.200 |
Why?
|
| Immunoconjugates | 1 | 2023 | 95 | 0.200 |
Why?
|
| Neuroendocrine Tumors | 1 | 2013 | 20 | 0.190 |
Why?
|
| Young Adult | 4 | 2025 | 4855 | 0.190 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2025 | 355 | 0.190 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2025 | 193 | 0.180 |
Why?
|
| Cell Cycle Proteins | 1 | 2025 | 404 | 0.180 |
Why?
|
| Aged, 80 and over | 4 | 2025 | 5657 | 0.180 |
Why?
|
| Age Factors | 1 | 2025 | 1592 | 0.170 |
Why?
|
| Aged | 7 | 2025 | 15090 | 0.170 |
Why?
|
| Tumor Lysis Syndrome | 1 | 2019 | 3 | 0.150 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2019 | 142 | 0.130 |
Why?
|
| Adolescent | 2 | 2025 | 6350 | 0.130 |
Why?
|
| Antineoplastic Agents | 2 | 2019 | 644 | 0.130 |
Why?
|
| Adult | 5 | 2025 | 17511 | 0.130 |
Why?
|
| Middle Aged | 5 | 2025 | 18440 | 0.130 |
Why?
|
| Mutation | 1 | 2025 | 2672 | 0.120 |
Why?
|
| Male | 6 | 2025 | 31297 | 0.110 |
Why?
|
| Female | 6 | 2025 | 34310 | 0.100 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2019 | 710 | 0.100 |
Why?
|
| United States | 1 | 2025 | 8166 | 0.090 |
Why?
|
| Humans | 8 | 2025 | 65654 | 0.090 |
Why?
|
| Recurrence | 2 | 2019 | 664 | 0.070 |
Why?
|
| Prognosis | 2 | 2025 | 1791 | 0.070 |
Why?
|
| Cyclophosphamide | 1 | 2025 | 84 | 0.060 |
Why?
|
| Transplantation, Homologous | 1 | 2025 | 250 | 0.060 |
Why?
|
| Survival Rate | 1 | 2025 | 847 | 0.050 |
Why?
|
| Chromogranin A | 1 | 2013 | 8 | 0.050 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2025 | 316 | 0.050 |
Why?
|
| Disease-Free Survival | 1 | 2013 | 245 | 0.050 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2013 | 420 | 0.040 |
Why?
|
| Treatment Outcome | 2 | 2025 | 5820 | 0.040 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2023 | 377 | 0.040 |
Why?
|
| Registries | 1 | 2025 | 934 | 0.040 |
Why?
|
| Retrospective Studies | 2 | 2025 | 6948 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2013 | 888 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2019 | 104 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2019 | 858 | 0.030 |
Why?
|
| Patient Safety | 1 | 2019 | 281 | 0.030 |
Why?
|